Taimur, S <br/><br/>
Microbiologically documented infections in patients undergoing high-dose melphalan and autologous stem cell transplantation for the treatment of light chain amyloidosis.  [electronic resource] 

 -  Transplant infectious disease : an official journal of the Transplantation Society  Apr 2013 
 - 187-94 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1399-3062 
<br/><br/><label>Standard No.: </label>10.1111/tid.12037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Amyloidosis--therapy<br/>Bacterial Infections--diagnosis<br/>Combined Modality Therapy<br/>Cross Infection--etiology<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Immunoglobulin Light Chains<br/>Male<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Mycoses--diagnosis<br/>Myeloablative Agonists--administration & dosage<br/>Postoperative Complications<br/>Risk Factors<br/>Stem Cell Transplantation--adverse effects<br/>Transplantation, Autologous